Form 4: Forrester Research Executive Nathaniel Swan Reports Stock Transactions
SEC Form 4 Filing
Nathaniel Swan, Chief Sales Officer of Forrester Research, reports the vesting of restricted stock units and acquisition of stock options.
Summary
- On April 1, 2025, Nathaniel Swan, Chief Sales Officer of Forrester Research, reported transactions involving Forrester Research, Inc. common stock and restricted stock units.
- 6,001 restricted stock units vested and converted into common stock.
- 2,684 shares were withheld by the issuer to satisfy tax obligations related to the vesting of restricted stock units.
- Swan was granted 33,333 restricted stock units that vest in four equal installments beginning April 1, 2026.
- Swan was also granted 66,666 non-qualified stock options exercisable in four equal installments beginning April 1, 2026, expiring on March 31, 2035.
- Following these transactions, Swan directly owns 9,666 shares of common stock, 18,002 restricted stock units from a previous grant, 33,333 restricted stock units from the current grant, and 66,666 non-qualified stock options.
Sentiment
Score: 6
Explanation: The sentiment is neutral. It's a routine filing reflecting standard compensation practices. There's no indication of unusual activity or cause for alarm or excessive optimism.
Positives
- The grant of restricted stock units and stock options to the Chief Sales Officer aligns his interests with those of the shareholders.
- The vesting of restricted stock units indicates continued employment and contribution to the company.
Future Outlook
The reporting person will continue to receive shares as the restricted stock units vest over the next three years, and the stock options become exercisable.
Industry Context
Form 4 filings are a routine part of corporate governance, providing transparency into the transactions of company insiders. These filings are closely watched by investors for signals about management's confidence in the company's future prospects.
Comparison to Industry Standards
- Stock option and RSU grants are a common form of compensation for executives at publicly traded companies like Forrester Research.
- The vesting schedules and terms of these grants are generally in line with industry standards for executive compensation.
- Companies like Gartner and IDC also utilize similar equity-based compensation plans for their executives.
Stakeholder Impact
- Shareholders may view the vesting of restricted stock units and granting of stock options as a positive sign, aligning management's interests with theirs.
- Employees may see this as a standard part of the company's compensation structure.
Key Dates
| Date | Description |
|---|---|
| 04/01/2024 | Reporting person was granted 24,003 Restricted Stock Units that vest and convert into common stock in four equal and consecutive installments beginning on the first anniversary of the grant date. |
| 04/01/2025 | Date of earliest transaction; vesting of restricted stock units and grant of additional RSUs and stock options. |
| 04/01/2025 | 6,001 Restricted Stock Units vest and convert into common stock. |
| 04/01/2025 | Reporting person was granted 33,333 Restricted Stock Units that vest and convert into common stock in four equal and consecutive installments beginning on the first anniversary of the grant date. |
| 04/01/2026 | First vesting date for the 33,333 Restricted Stock Units granted on April 1, 2025. |
| 03/31/2035 | Expiration date for the Non-Qualified Stock Options (Right to Buy) granted on April 1, 2025. |
| 04/03/2025 | Date of Form 4 filing. |
Keywords
Form 4, insider trading, stock options, restricted stock units, Nathaniel Swan, Forrester Research, FORR, beneficial ownership
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.